Investing

Editor's Top Picks

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form Investing

VW’s All-American Atlas Is a Three-Row Contender

Volkswagen is preparing an assault on the American SUV market, with Atlas driving the plans. “The

FDA Moves to Soothe Fears of Drug Shortages After Tornado Hits Pfizer Plant

The Food and Drug Administration is moving to soothe worries that Wednesday’s tornado strike on

Philip Morris’s Earnings Outlook Falls Short. Why the CFO Is Upbeat.

Philip Morris International posted higher-than-expected earnings for the quarter, but its outlook for the year

Watch the Dow Transports for clues about the economy — not the stock market

The Dow Jones Transportation Average DJT, -0.20% has been on a tear in recent weeks,

Buy these stocks if you think the U.S. dollar will keep getting weaker

Non-U.S. stocks will be particularly attractive to U.S. investors if the U.S. dollar continues to

Gold prices down for the session, up modestly for the week as investors look to Fed meeting

Gold prices ended lower on Friday, holding on to a modest gain for the week

What To Expect From U.S. CPI For The Remainder Of 2023

U.S. headline inflation has come down sharply from peak levels of summer 2022, but not

Slate Grocery Names Joe Pleckaitis as Chief Financial Officer

By Brenda León Slate Grocery REIT named Joe Pleckaitis as its next chief financial officer,

Gilead Discontinues Study of Immunotherapy to Treat Blood Cancers

By Denny Jacob Gilead Sciences has discontinued its Phase 3 study of magrolimab in higher-risk

Mira Pharmaceuticals Files for IPO

By Sabela Ojea Mira Pharmaceuticals has filed for an initial public offering, according to a

Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals

By Denny Jacob AMC Entertainment's proposed equity transactions were blocked after a judge rejected a

FDA Doesn’t Expect Immediate Significant Impact to Drug Supply Following Tornado at Pfizer Plant

By Denny Jacob The Food and Drug Administration on Friday said there shouldn't be an

An ETF that can’t go down? This new ‘buffer’ fund is designed to provide 100% protection against stock-market losses

Hello! This is MarketWatch reporter Isabel Wang bringing you this week’s ETF Wrap. In this

Venture Capital’s Funk Bodes Poorly for Private Company Valuations

If there’s one thing I know almost nothing about, it’s cricket. To my American eyes,

Economic Paradise, or the Abyss?

To the Editor:Despite the most inverted yield curve since 1981, the first contraction in the